Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2017 1
2018 2
2019 2
2020 4
2021 9
2022 10
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Metronomic Chemotherapy for Metastatic Breast Cancer.
Krajnak S, Battista MJ, Hasenburg A, Schmidt M. Krajnak S, et al. Oncol Res Treat. 2022;45(1-2):12-17. doi: 10.1159/000520236. Epub 2021 Nov 18. Oncol Res Treat. 2022. PMID: 34794154 Free article. Review.
Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer.
Almstedt K, Krauthauser L, Kappenberg F, Wagner DC, Heimes AS, Battista MJ, Anic K, Krajnak S, Lebrecht A, Schwab R, Brenner W, Weikel W, Rahnenführer J, Hengstler JG, Roth W, Hasenburg A, Stewen K, Schmidt M. Almstedt K, et al. Among authors: krajnak s. Cancers (Basel). 2023 Feb 23;15(5):1413. doi: 10.3390/cancers15051413. Cancers (Basel). 2023. PMID: 36900203 Free PMC article.
Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer.
Heimes AS, Almstedt K, Krajnak S, Runkel A, Droste A, Schwab R, Stewen K, Lebrecht A, Battista MJ, Brenner W, Hasenburg A, Gehrmann M, Hengstler JG, Schmidt M. Heimes AS, et al. Among authors: krajnak s. Biomedicines. 2022 Oct 21;10(10):2656. doi: 10.3390/biomedicines10102656. Biomedicines. 2022. PMID: 36289918 Free PMC article.
Effects of intermittent fasting on quality of life tolerance of chemotherapy in patients with gynecological cancers: study protocol of a randomized-controlled multi-center trial.
Schmidt MW, Brenner W, Gebhard S, Schmidt M, Singer S, Weidenbach L, Hahn H, Puzankova D, Blau-Schneider B, Lehnert A, Battista MJ, Almstedt K, Lütkemeyer A, Radsak MP, Mähringer-Kunz A, Krajnak S, Linz VC, Schwab R, Gabriel B, Hasenburg A, Anic K. Schmidt MW, et al. Among authors: krajnak s. Front Oncol. 2023 Jul 19;13:1222573. doi: 10.3389/fonc.2023.1222573. eCollection 2023. Front Oncol. 2023. PMID: 37538111 Free PMC article.
Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer.
Almstedt K, Heimes AS, Kappenberg F, Battista MJ, Lehr HA, Krajnak S, Lebrecht A, Gehrmann M, Stewen K, Brenner W, Weikel W, Rahnenführer J, Hengstler JG, Hasenburg A, Schmidt M. Almstedt K, et al. Among authors: krajnak s. Eur J Cancer. 2022 Sep;173:10-19. doi: 10.1016/j.ejca.2022.06.012. Epub 2022 Jul 12. Eur J Cancer. 2022. PMID: 35839597
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer.
Almstedt K, Mendoza S, Otto M, Battista MJ, Steetskamp J, Heimes AS, Krajnak S, Poplawski A, Gerhold-Ay A, Hasenburg A, Denkert C, Schmidt M. Almstedt K, et al. Among authors: krajnak s. Breast Cancer Res Treat. 2020 Jul;182(1):137-146. doi: 10.1007/s10549-020-05688-1. Epub 2020 May 20. Breast Cancer Res Treat. 2020. PMID: 32436145 Free PMC article.
Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast Cancer.
Schmidt M, Edlund K, Hengstler JG, Heimes AS, Almstedt K, Lebrecht A, Krajnak S, Battista MJ, Brenner W, Hasenburg A, Rahnenführer J, Gehrmann M, Kellokumpu-Lehtinen PL, Wirtz RM, Joensuu H. Schmidt M, et al. Among authors: krajnak s. Cancers (Basel). 2021 Jul 20;13(14):3626. doi: 10.3390/cancers13143626. Cancers (Basel). 2021. PMID: 34298839 Free PMC article.
31 results